| ISIN | CH0022012717 |
|---|---|
| Valor Number | 2201271 |
| Bloomberg Global ID | |
| Fund Name | DWS (CH) - Swiss Equity High Conviction ED CHF Dis |
| Fund Provider |
DWS CH AG
Prime Tower, Hardstrasse 201 8005 Zürich |
| Fund Provider | DWS CH AG |
| Representative in Switzerland | |
| Distributor(s) | DWS CH AG |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 358.75 CHF | 30.10.2025 |
|---|---|---|
| Previous Price * | 357.39 CHF | 29.10.2025 |
| 52 Week High * | 364.08 CHF | 08.10.2025 |
| 52 Week Low * | 305.69 CHF | 09.04.2025 |
| NAV * | 358.75 CHF | 30.10.2025 |
| Issue Price * | ||
| Redemption Price * | 358.75 CHF | 30.10.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 75,579,427 | |
| Unit/Share Assets *** | 36,529,744 | |
| Trading Information SIX | ||
| YTD Performance | +11.03% |
30.12.2024 - 30.10.2025
30.12.2024 30.10.2025 |
|---|---|---|
| 1 month | +1.48% |
30.09.2025 - 30.10.2025
30.09.2025 30.10.2025 |
| 3 months | +0.71% |
30.07.2025 - 30.10.2025
30.07.2025 30.10.2025 |
| 6 months | +3.68% |
30.04.2025 - 30.10.2025
30.04.2025 30.10.2025 |
| 1 year | +7.70% |
30.10.2024 - 30.10.2025
30.10.2024 30.10.2025 |
| 2 years | +25.59% |
30.10.2023 - 30.10.2025
30.10.2023 30.10.2025 |
| 3 years | +25.84% |
31.10.2022 - 30.10.2025
31.10.2022 30.10.2025 |
| 5 years | +47.12% |
30.10.2020 - 30.10.2025
30.10.2020 30.10.2025 |
| Equity Participation Rate in % | 86.50 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nestle SA | 16.41% | |
|---|---|---|
| Novartis AG Registered Shares | 11.75% | |
| Roche Holding AG | 10.50% | |
| UBS Group AG | 6.31% | |
| Compagnie Financiere Richemont SA Class A | 5.51% | |
| Zurich Insurance Group AG | 5.10% | |
| ABB Ltd | 3.95% | |
| Holcim Ltd | 3.94% | |
| Sika AG | 3.65% | |
| Geberit AG | 3.40% | |
| Last data update | 31.12.2023 | |
| TER | 1.33% |
|---|---|
| TER date | 30.06.2025 |
| Performance Fee *** | 15.00% |
| PTR | |
| Max. Management Fee *** | 1.00% |
| Ongoing Charges *** | 1.00% |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |